A1 Refereed original research article in a scientific journal

Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk



Authors: Raitakari OT, Makinen VP, McQueen MJ, Niemi J, Juonala M, Jauhiainen M, Salomaa V, Hannuksela ML, Savolainen MJ, Kesaniemi YA, Kovanen PT, Sundvall J, Solakivi T, Loo BM, Marniemi J, Hernesniemi J, Lehtimaki T, Kahonen M, Peltonen M, Leiviska J, Jula A, Anand SS, Miller R, Yusuf S, Viikari JSA, Ala-Korpela M

Publisher: ELSEVIER IRELAND LTD

Publication year: 2013

Journal: Atherosclerosis

Journal name in source: ATHEROSCLEROSIS

Journal acronym: ATHEROSCLEROSIS

Number in series: 1

Volume: 226

Issue: 1

First page : 245

Last page: 251

Number of pages: 7

ISSN: 0021-9150

DOI: https://doi.org/10.1016/j.atherosclerosis.2012.10.049


Abstract
Conclusions: Serum cholesterol, HDL-cholesterol and triglycerides can be used to compute clinically useful estimates of apoB and apoA1. Using this methodology, estimates of apolipoproteins could be routinely added to laboratory reports to complement lipoprotein lipids in risk assessment. (C) 2012 Elsevier Ireland Ltd. All rights reserved.


Research Areas



Last updated on 2024-26-11 at 21:28